Shannon Brow
Nurse Practitioner · Houston, TXNPI 1558540930
Payments from drug & device makers
Across 81 payments — averaging $42.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$938
- AstraZeneca$528
- Amgen$339
- Aurinia Pharma U.S., Inc.$236
- AbbVie$193
- Otsuka America Pharmaceutical, Inc.$183
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,452100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 13 | $938 |
| AstraZeneca | 8 | $528 |
| Amgen | 8 | $339 |
| Aurinia Pharma U.S., Inc. | 2 | $236 |
| AbbVie | 10 | $193 |
| Otsuka America Pharmaceutical, Inc. | 7 | $183 |
| Sequel Med Tech, LLC | 1 | $148 |
| Boehringer Ingelheim | 7 | $146 |
| Tandem Diabetes Care, Inc. | 1 | $97 |
| Cequr Corporation | 1 | $90 |
| Dexcom, Inc. | 2 | $79 |
| Abbott | 3 | $58 |
| Novo Nordisk | 1 | $56 |
| Radius Health, Inc. | 1 | $51 |
| Johnson & Johnson | 3 | $50 |
| Insulet Corporation | 2 | $42 |
| Boston Scientific | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Bayer | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| GSK | 1 | $18 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,452 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $25,957 |
| JardianceEmpagliflozin | 16 | $24,918 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 16 | $24,376 |
| FarxigaDapagliflozin Propanediol | 13 | $18,087 |
| MounjaroTirzepatide | 15 | $16,640 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $10,191 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 23 | $2,063 |
| Novolog FlexpenInsulin Aspart | 11 | $1,725 |
| Rosuvastatin Calcium | 86 | $1,226 |
| Omeprazole | 40 | $773 |
| Gabapentin | 29 | $628 |
| Fluticasone Propionate | 17 | $364 |
| Metoprolol Succinate | 33 | $333 |
| Lisinopril | 64 | $316 |
| FenofibrateFenofibrate,micronized | 12 | $295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $146 | $24,91816 claims |
| AstraZenecaFarxiga | $528 | $18,08713 claims |
| Lilly USA, LLCMounjaro | $38 | $16,64015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Houston
- Melanie MorrisHouston$254K
- Kelly BrassilHouston$194K
- Julie WeatherlyHouston$87K
- Katrina KingHouston$44K
- Allison TurnerHouston$37K
- Tiffany RichardsHouston$37K
- Bianca CaloHouston$36K
- Arby CohenHouston$23K
- Virginia MarxHouston$19K
- Hermeyone BellHouston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.